-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Among the risk factors for death from new coronary pneumonia , type II diabetes is one of the more important and common factors.
Coronavirus disease
Recently, researchers investigated the impact of different hypoglycemic prescriptions for patients with type II diabetes on the risk of death from new coronary pneumonia.
Recently, researchers investigated the impact of different hypoglycemic prescriptions for patients with type II diabetes on the risk of death from new coronary pneumonia.
This study was carried out in the United Kingdom and is a national observational cohort study of diabetic patients.
This study contains a total of 2,851,465 type 2 diabetes patients data.
Infection receiving metformin risk of death in patients was 0.
Studies have found that some hypoglycemic drugs can reduce the risk of death in diabetic patients after contracting new coronary pneumonia, but the risk difference is small, and the risk of confusion cannot be ruled out.
Some hypoglycemic drugs can reduce the risk of death in diabetic patients after contracting new coronary pneumonia, but the risk difference is small, and the risk of confusion cannot be ruled out.
Original source:
Prof Kamlesh Khunti et al.
Prescription of glucose-lowering therapies and risk of COVID-19 Leave a message here